Progress in respiratory management of bulbar complications of motor neuron disease/amyotrophic lateral sclerosis?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed.

1. Pan-Asian consortium for treatment and research in ALS (PACTALS) guidelines for management of amyotrophic lateral sclerosis.The Lancet regional health. Western Pacific · 2025
   Review
2. Rethinking ALS: Current understanding and emerging therapeutic strategies.AIMS neuroscience · 2025
   Review
3. Pilot observational cohort study to determine whether waveform and flow traces from mechanical insufflation-exsufflation (MI-E) can be used to identify laryngeal responses to MI-E and thus optimise treatment algorithms in neuromuscular patients in a tertiary centre: a protocol description.BMJ open respiratory research · 2024
   Article
4. The role of lung volume recruitment therapy in neuromuscular disease: a narrative review.Frontiers in rehabilitation sciences · 2023
   Review
5. Clinicopathological correlates of pyramidal signs in multiple system atrophy.Annals of clinical and translational neurology · 2022
   Article
6. Developing an intrasalivary gland botox service for patients receiving long-term non-invasive ventilation at home: a single-centre experience.BMJ open respiratory research · 2022
   Article
7. The burden of sialorrhoea in chronic neurological conditions: current treatment options and the role of incobotulinumtoxinA (Xeomin®).Therapeutic advances in neurological disorders · 2019
   Article
8. Considerations for chest clearance and cough augmentation in severe bulbar dysfunction: a case study.Canadian journal of respiratory therapy : CJRT = Revue canadienne de la therapie respiratoire : RCTR · 2018
   Article

Corrections and comments

• Comment on
  Laryngeal response patterns influence the efficacy of mechanical assisted cough in amyotrophic lateral sclerosis.2017

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as